The International Trade Commission published notices in the March 5 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The Commerce Department published notices in the Federal Register March 5 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department has released the final results of the antidumping duty administrative review on seamless carbon and alloy steel standard, line and pressure pipe (seamless pipe) from Ukraine (A-823-819). These final results will be used to set final assessments of AD on importers for subject merchandise entered Feb. 10, 2021, through July 31, 2022.
The Commerce Department has published the preliminary results of its antidumping and countervailing duty administrative reviews on certain cut-to-length plate (CTL plate) from South Korea (A-580-836/C-580-837). In the final results of this review, Commerce will set AD assessment rates for subject merchandise for the companies under review entered Feb. 1, 2022, through Jan. 31, 2023, and CVD assessment rates for entries Jan. 1, 2022, through Dec. 31, 2022.
Whole garlic cloves in brine imported from China by Roland Goods aren't subject to an antidumping duty order on fresh garlic from China, the Commerce Department said in a March 1 scope ruling.
The International Trade Commission published notices in the March 4 Federal Register on the following AD/CVD injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
Medtronic seeks a ban on imports of medical programmers with printed circuit boards from Axonics that allegedly infringe on its patents, it told the International Trade Commission in a Section 337 complaint filed last week. Medtronic says Axonics is importing sacral neuromodulation systems that rely on its patented technology, including devices for use with Axonics’ F15 and R20 sacral neuromodulation systems. The surgically implanted systems are used to control symptoms of overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence through neural stimulation. Medtronic seeks a limited exclusion order and cease and desist order banning importation and sale of infringing products from Axonics. Comments are due to the ITC March 12.
The International Trade Commission will consider whether to issue a general exclusion order banning all imports of network equipment supporting NETCONF standards that allegedly infringe patents held by Optimum Communications Services (ITC Inv. No. 337-TA-1391), the ITC said in a March 4 notice. Optimum's January complaint said imports of the goods, used for network management systems for managing remote network elements, violate Section 337 by infringing on its patented technologies that “improve cost-efficiency, reliability and performance of network configuration and monitoring" (see 2401250040). The ITC will also consider cease and desist orders against Changsha Silun, Hunan Maiqiang, Hunan Zikun and Guangzhou Qiton, it said.
The Commerce Department published notices in the Federal Register March 4 on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms or effective dates will be detailed in another ITT article):
The Commerce Department has released the preliminary results of its antidumping duty administrative review on stainless steel bar from India (A-533-810). In the final results of this review, Commerce may set assessment rates for subject merchandise from four companies entered Feb. 1, 2022, through Jan. 31, 2023. It has preliminarily determined that there is no dumping by the companies under review.